Topics

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection,Bacterial Infections, Date of authorisation: 20/09/2018, Revision: 1, Status: Authorised

05:41 EDT 10 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection,Bacterial Infections, Date of authorisation: 20/09/2018, Revision: 1, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection,Bacterial Infections, Date of authorisation: 20/09/2018, Revision: 1, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Xerava, eravacycline, Infection,Bacterial Infections, Date of authorisation: 20/09/2018, Revision: 1, Status: Authorised"

Quick Search

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...